William Tembo: Understanding Stroke Through Landmark Clinical Trials
William Tembo, Stroke Research Fellow, Acute Care Research Coordinator at University of Minnesota, shared on LinkedIn:
”Trial Thursday
Someone recently told me, ‘Stroke is stroke. Every stroke is treated the same way.’
It is an understandable thought. Many stroke patients receive similar core treatments such as antiplatelet therapy, blood pressure control, statins, and risk factor management.
From the outside, it can look like the approach is always the same.
But in reality, stroke is not one disease.
Stroke can result from several different mechanisms including large artery atherosclerosis, cardioembolism, small vessel disease, arterial dissection, and other less common causes.
Each mechanism carries different risks and may require different treatment strategies.
- Some patients need antiplatelets.
- Others require anticoagulation.
- Some benefit from carotid intervention.
- Others from endovascular thrombectomy.
These differences are not theoretical. They come from evidence generated by major stroke trials that have shaped modern stroke care.
So I am starting a series called Trial Thursday.
Each week I will break down one important stroke trial and discuss
- the clinical question
- the study design
- the key results
- and how it changed practice
Because in stroke care, the mechanism matters and the evidence matters.
Stay tuned.”

Stay updated with Hemostasis Today.
-
Mar 13, 2026, 20:35Jessica Garcia: New Evidence on Thrombin Generation Patterns in Children with Hemophilia A
-
Mar 13, 2026, 20:11Christoph B. Olivier: New Research from Marius Wessinger on Predicting Therapy Success After Pulmonary Embolism
-
Mar 13, 2026, 19:53Wolfgang Miesbach Announces the New English Edition of “Gene Therapy Concepts in the Treatment of Haemophilia”
-
Mar 13, 2026, 17:21Emmanuel J Favaloro: Acquired Hemostasis Disorders Featured in New Issue of Seminars in Thrombosis and Hemostasis
-
Mar 13, 2026, 17:17Paolo Zamboni: New Insights from Australia on Jugular and Azygous Vein Chronic Obstruction
-
Mar 13, 2026, 17:06Srishti Goyal: Can Thalassemia Major Be Prevented?
-
Mar 13, 2026, 16:59Tagreed Alkaltham: Preventing the Risk of Transfusion Reactions Before They Occur
-
Mar 13, 2026, 16:52Giuseppe Lippi: New Insights Into Antiphospholipid Antibodies and Cardiovascular Thrombosis
-
Mar 13, 2026, 16:51Ahmet Dirican: Apixaban vs Rivaroxaban in Acute VTE